Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

Clinical trial NCT01755325 · SUSPENDED

Trial details

NCT number: NCT01755325
Sponsor: Junmin Li
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia

Start date: 2012-11-01
Primary completion: 2018-12-01
Enrollment: 680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.